Ryan Specialty Holdings Inc. RYAN
37.89
1.15
3.13%
as of 25 Sep
- Market cap
- $9.4B
- P/E
- 49.2×
Follow RYAN
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
49.04 | 39.69 | 105.37 | 104.37 |
+8 more quarters Free account |
P/S ratio |
1.47 | 1.38 | 2.15 | 2.43 | |
P/FCF ratio |
9.60 | 7.90 | 11.47 | 12.67 | |
P/Operating CF |
16.14 | (26.07) | 24.96 | 42.50 | |
P/B ratio |
4.66 | 3.58 | 5.24 | 5.85 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.56 | 2.46 | 3.20 | 3.53 | |
EV/EBITDA |
10.60 | 9.82 | 12.24 | 12.98 | |
EV/Operating CF |
14.72 | 12.57 | 15.17 | 16.32 | |
EV/FCF |
16.69 | 14.09 | 17.05 | 18.36 | |
Quick Ratio |
0.13 | 0.13 | 0.12 | 0.13 | |
Current Ratio |
1.00 | 1.02 | 0.98 | 1.00 | |
Net Debt/EBITDA |
13.90 | 20.52 | 18.87 | 17.16 | |
Debt/Assets |
30.36% | 32.41% | 31.73% | 34.42% | |
Debt/Equity |
3.58 | 2.93 | 2.67 | 2.75 | |
Asset Turnover |
0.28 | 0.30 | 0.30 | 0.32 | |
Operating CF/Net income |
6.92 | (9.49) | 32.99 | 5.46 | |
Capex/Depreciation |
(0.26) | (0.18) | (0.22) | (0.21) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
70.94% | 75.95% | 75.90% | 73.95% | |
Intangible Assets out of Total Assets |
0.28 | 0.30 | 0.32 | 0.33 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 6.76% | |
Graham Net Nets |
(0.91) | (0.97) | (0.65) | (0.58) | |
Graham Number |
11.85 | 13.42 | 10.42 | 10.82 | |
Earnings Yield |
2.04% | 2.52% | 0.95% | 0.96% | |
Free Cash Flow Yield |
10.42% | 12.65% | 8.72% | 7.89% | |
Revenue per Share |
7.32 | 6.15 | 5.90 | 5.90 | |
Operating CF per Share |
2.34 | (1.29) | 2.07 | 1.33 | |
Capex per Share |
(0.15) | (0.10) | (0.14) | (0.13) | |
Free Cash Flow per Share |
2.19 | (1.40) | 1.93 | 1.20 | |
Cash per Share |
1.12 | 1.20 | 1.24 | 1.20 | |
Shareholders Equity per Share |
8.11 | 9.42 | 9.85 | 9.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.11 | 9.42 | 9.85 | 9.63 | |
Free Cash Flow |
274.31 | (180.68) | 245.97 | 153.18 | |
Working Capital |
(13.03) | 122.87 | (128.57) | (10.06) | |
Capital Expenditures |
(18.72) | (13.26) | (17.27) | (16.48) | |
Net Current Asset Value |
(4,307.92) | (4,213.76) | (4,249.94) | (4,173.15) | |
EV/EBIT |
17.23 | 15.94 | 19.78 | 20.43 | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
4.62% | 2.22% | 1.06% | 4.12% | |
Price to Operating Income |
9.91 | 8.95 | 13.31 | 14.10 | |
| Other line items | |||||
Average Receivables |
613.06 | 498.87 | 439.35 | 387.22 | |
Average Payables |
268.25 | 269.46 | 266.80 | 231.84 | |
Average Assets |
11,296.20 | 10,450.84 | 10,107.04 | 9,165.18 | |
Average Common Equity |
1,099.15 | 1,138.18 | 1,176.17 | 1,166.70 |
Columns are period end dates